MDS trials: what should patients be looking for?
Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses the upcoming myelodysplastic syndromes (MDS) clinical trials. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
Get great new content delivered to your inboxSign up
5th March 2020
More from Rena Buckstein